Heart Rate Variability by Age and Gender

Heart rate variability declines steadily with age and tends to be higher in men than in women for most standard measures, though the size of the sex gap is considerably smaller than the effect of aging itself. HRV serves as a window into how flexibly your autonomic nervous system can adjust your heart’s rhythm from beat to beat, and both age and sex shape that flexibility in ways that matter for long-term health. The story gets more interesting once you look at how hormones, fitness, sleep, and even the type of wearable you use can shift the numbers.

What HRV Actually Reflects

Your heart does not beat like a metronome. The intervals between consecutive beats fluctuate constantly, driven largely by the push and pull of your sympathetic (“fight or flight”) and parasympathetic (“rest and digest”) nervous systems. HRV captures these fluctuations, and researchers treat it as a non-invasive marker of how well the vagus nerve and the broader autonomic system are functioning.¹ Higher HRV generally signals a system that can respond quickly to changing demands, whether that means ramping up during exercise or calming down during sleep. Lower HRV suggests a system that has lost some of that adaptive range.

There are dozens of ways to quantify HRV, but they fall into two broad families. Time-domain metrics look at the variation in beat-to-beat intervals directly. SDNN, for instance, captures overall variability, while RMSSD and pNN50 emphasize the rapid, beat-to-beat changes most closely linked to vagal (parasympathetic) activity. Frequency-domain metrics break the signal into rhythmic components: high-frequency power (HF) is tied primarily to parasympathetic activity and breathing, while low-frequency power (LF) reflects a mix of sympathetic and parasympathetic input. These distinctions matter because age and sex do not affect every metric equally.

How HRV Changes Across the Lifespan

In infants and young children, HRV is relatively low but rises steeply. A study tracking children from birth through young adulthood found a general increase in both low-frequency and high-frequency power from birth to about age six, followed by a gradual decline into the mid-twenties.² So the peak of HRV lands somewhere in later childhood or early adolescence, depending on the metric. After that, the trajectory points downward for the rest of life.

The rate of that decline, though, is not constant. A large longitudinal study found that HRV dropped faster in younger age groups and slowed its descent in older ones, a pattern that held for both sexes.³ Put differently, the steepest drop happens in early and middle adulthood, while the decline from your sixties onward is more gradual. A study of adults 65 and older confirmed this, showing that frequency-domain HRV decreased more between ages 65 and 69 than between 70 and 74, and only minimally after 75.⁴

Not all metrics fade at the same pace. A study spanning nine decades of life found that overall variability (SDNN) declined only gradually, still sitting at about 60% of young-adult values by the tenth decade. But pNN50, which zeros in on rapid vagal fluctuations, dropped to roughly a quarter of its youthful level by the sixth decade and then essentially plateaued.⁵ The practical takeaway: the parasympathetic-specific slice of your heart’s variability takes its biggest hit in midlife, while broader measures of overall autonomic flexibility erode more slowly.

Why Aging Reduces HRV

The decline is not just about the nervous system wearing out. Research in animal models has shown that pacemaker cells in the heart itself become less responsive with age, both to signals from the autonomic nerves and to their own internal regulatory machinery. The autonomic system actually tries to compensate for these intrinsic pacemaker-cell changes, but that compensation comes at a cost: it narrows the range of beat-to-beat variation.⁶ So aging hits HRV from two directions at once: the heart’s own timekeeping machinery becomes stiffer, and the nervous system’s attempts to keep pace inadvertently flatten out variability.

Sex Differences in HRV

Across most studies, men show higher overall HRV than women on the time-domain metrics that capture total variability. In the Baependi Heart Study, a community-based sample from Brazil, men had significantly higher SDNN and SDANN values than women across age groups, and pNN50 was also higher in men among younger adults.⁷ Frequency-domain analyses tell a similar story for total power, very-low-frequency, and low-frequency components, all of which tend to be lower in women.⁸

But there is an important nuance. When researchers look specifically at high-frequency power and related normalized measures, which reflect parasympathetic tone most directly, the gap sometimes reverses. A study of healthy young adults aged 18 to 30 found that women had higher HF power and higher normalized HF values than men, pointing to stronger parasympathetic input to the heart.⁹ Men, meanwhile, had higher LF power and a higher LF/HF ratio, suggesting relatively more sympathetic contribution. So the headline “men have higher HRV” is true for total and broad-spectrum variability, but women may actually have an edge in the specific vagal component. This distinction is easy to miss if you only look at one metric.

The size of these sex differences is modest compared to the effect of aging. As one study put it, gender is a real determinant of HRV in healthy people, but a lesser one than age.⁸ If you are comparing a sedentary 25-year-old man and a fit 25-year-old woman, the fitness difference may easily swamp the sex difference.

How the Menstrual Cycle Shifts the Numbers

For premenopausal women, HRV is not a fixed number from week to week. Sympathetic nervous activity tends to be higher in the secretory (luteal) phase of the menstrual cycle, while parasympathetic tone predominates in the proliferative (follicular) phase.¹⁰ The main hormonal driver appears to be progesterone. Two within-person studies found that higher-than-usual progesterone levels predicted lower-than-usual HRV in the same woman, and that mid-luteal HRV was lower than at other cycle points. Estrogen, by contrast, did not show a significant independent effect.¹¹

This means that a single HRV reading for a cycling woman can look quite different depending on when in the month it was taken. If you are tracking your own HRV over time, comparing readings from the same cycle phase gives a more meaningful trend than lumping all days together.

Menopause, Hormone Therapy, and Oral Contraceptives

Menopause shifts the autonomic balance toward sympathetic dominance.¹² Studies comparing pre- and postmenopausal women have found lower LF and HF power after menopause, though once you adjust for age and body mass index, much of that difference fades, making it hard to separate the hormonal effect from the simple passage of time.¹³ Still, one finding stood out even after adjustment: postmenopausal women showed a decline in protective high-frequency power under a cardiovascular challenge, suggesting reduced vagal reserve when it mattered most.¹³

If hormone therapy enters the picture, the type matters. A review of the evidence found that estrogen-only menopausal hormone therapy tended to support HRV in most studies, but adding a progestogen to the regimen appeared to cancel that benefit.¹⁴ Oral contraceptives, by contrast, did not appear to alter vagal modulation of the heart in healthy young women.¹⁴ A dedicated study comparing high-hormone and low-hormone pill phases found no significant difference in any HRV component, heart rate, or blood pressure between the two phases.¹⁵ In a way, that makes sense: oral contraceptives suppress the natural progesterone surge that drives the cycle-related HRV dip, flattening the month-to-month fluctuation.

Pregnancy Adds Another Layer

During pregnancy, HRV follows its own arc. A continuous-monitoring study found that younger pregnant women had higher parasympathetic metrics during the second trimester, but by the third trimester and the postpartum period, the relationship shifted: younger women actually showed lower SDNN, RMSSD, and HF than older pregnant women.¹⁶ The usual “younger equals higher HRV” assumption does not hold neatly in late pregnancy, likely because the massive cardiovascular and hormonal demands of the third trimester interact with age in unexpected ways.

Why Low HRV Is a Health Warning Sign

The clinical stakes behind these numbers are real. A large meta-analysis pooling data across both healthy people and patients with existing disease found that lower HRV consistently predicted higher mortality, regardless of age, sex, or continent.¹⁷ When people in the lowest quarter of short-term RMSSD were compared with everyone else, their risk of death was roughly 56% higher. In populations without known cardiovascular disease, low SDNN was linked to about a 35% higher risk of a first fatal or nonfatal cardiovascular event.¹⁸

Among people who already have heart disease, the relationship is even steeper. A meta-analysis of cohort studies in patients with cardiovascular conditions found that low HRV more than doubled the risk of all-cause death and raised the risk of cardiovascular events by about 40%, with the strongest associations seen in patients who had suffered acute heart attacks.¹⁹ Because HRV naturally declines with age and tends to be somewhat lower in women on total-variability measures, age- and sex-specific reference ranges are essential for interpreting what a given number actually means for your risk.

The Sex Paradox in Depression and Cardiovascular Risk

One of the stranger findings in this field involves depression. Women generally have greater vagal tone than men, which should, in theory, be protective. But among people with depression, women face a higher risk of adverse cardiovascular events than men, despite that vagal advantage.²⁰ The mechanisms behind this paradox are still being investigated, but it suggests that the relationship between HRV and heart health is not as straightforward as “higher equals safer” once you layer in mental health and hormonal factors.

How Stress Responses Differ by Age and Sex

Under acute psychological stress, men and women show distinct autonomic signatures. A lab study using a standard psychosocial stressor found that cortisol rose only in men, while women showed a significant increase in the LF/HF ratio, a marker of sympathovagal shift. In both sexes, these changes persisted even after a recovery period, meaning the autonomic system did not simply snap back to baseline once the stressor ended.²¹ Age adds another dimension: older men and women reached similar peak heart rate responses during a stress task, but only men returned to their baseline during the observation window, while women’s recovery lagged behind.²² For older women in particular, prolonged autonomic activation after stress may be an underappreciated contributor to cardiovascular wear and tear over time.

Exercise as a Counter to Age-Related Decline

The age-related slide in HRV is not entirely irreversible. Aerobic training in older adults has been shown to increase global HRV and vagal indices, effectively pushing back against the decline that comes with sedentary aging.²³ A controlled study in elderly participants found that only the aerobic training group, and not a stretching-control group, increased vagal-mediated HRV parameters. The same group also improved on a cognitive flexibility test, hinting at a connection between the cardiovascular and cognitive benefits of exercise.²⁴ You are not going to restore the HRV of a teenager through jogging, but regular aerobic activity appears to be one of the most reliable ways to keep the autonomic system more flexible as you age.

Sleep, Breathing Patterns, and HRV in Older Adults

HRV during sleep tells a different story in older adults than in younger ones. In young people, sleep is associated with clear stage-dependent shifts in autonomic tone: deep slow-wave sleep drives parasympathetic activity up, while REM sleep involves more sympathetic input. In older adults, those stage-dependent variations largely vanish. SDNN and frequency-domain power all drop during sleep compared to younger subjects, and there is an overall loss of parasympathetic dominance that may be linked to the well-known reduction in slow-wave sleep with aging.²⁵

Complicating matters, about 18% of sleep time in the older adults in this study featured periodic breathing, a pattern of rhythmic waxing and waning of breath depth. This periodic breathing, which appeared most often during REM sleep, actually inflated certain HRV metrics by introducing large, slow oscillations in heart rate that had nothing to do with healthy autonomic flexibility. If you or your doctor are interpreting overnight HRV data from a wearable, it is worth knowing that breathing abnormalities common in older sleepers can artificially boost some numbers while the underlying vagal health is actually worse than it looks.²⁵

Wearables, Measurement Length, and Age-Related Accuracy Issues

Consumer wearables have made HRV tracking accessible to millions, but the technology has age-specific blind spots. Most wrist-worn devices use optical sensors (photoplethysmography, or PPG) rather than the chest-strap electrocardiogram sensors used in clinical research. A comparative study found that the agreement between PPG-derived and ECG-derived HRV values was generally lower in people over 40, likely because age-related increases in arterial stiffness alter the shape of the pulse wave the optical sensor reads.²⁶ If you are over 40 and relying on a wrist device for HRV data, expect somewhat noisier readings than a younger user would get from the same gadget.

Recording length also matters. A widely cited norms paper cautioned that 24-hour, short-term (around five minutes), and ultra-short-term HRV values are not interchangeable.²⁷ Many commercial apps report overnight or morning snapshots, which can be useful for tracking personal trends but should not be compared directly to the reference ranges derived from clinical 24-hour Holter recordings. If your app says your RMSSD is 28 ms from a one-minute morning reading, that is not the same thing as a 28 ms from a full-day recording, and comparing it to published norms built on full-day data will mislead you.

Genetics and Ethnicity

Age and sex are not the only demographic variables that shape HRV. A genome-wide association study involving tens of thousands of participants identified multiple genetic loci linked to RMSSD, SDNN, and high-frequency power. Many of these associations replicated across individuals of European ancestry, Hispanic/Latino heritage, and African-American ancestry, though some loci showed weaker or no associations in certain ethnic groups.²⁸ The practical implication is that your baseline HRV is partly heritable, and published norms drawn primarily from European-ancestry populations may not perfectly apply to everyone. As wearable-driven HRV tracking expands globally, building ethnicity-aware reference ranges will become increasingly important for accurate interpretation.

Reading Your Own Numbers in Context

Given everything above, a useful framework for interpreting your own HRV data involves a few layers. First, compare yourself to yourself. Day-to-day and week-to-week trends in your own readings are more informative than a single comparison to a population average. Second, if you do want to benchmark, look for norms stratified by both age and sex: a 55-year-old woman and a 25-year-old man inhabit different HRV universes, and a single “normal range” that ignores that difference is close to useless. Third, consider the conditions of the measurement. Time of day, body position, recording length, device type, menstrual cycle phase, recent exercise, sleep quality, and even acute stress can all shift the reading substantially. A low number on a morning after poor sleep and a stressful day tells you less about your long-term autonomic health than a consistent downward trend over months.

For women specifically, tracking cycle phase alongside HRV can prevent false alarms. A dip in HRV during the luteal phase is normal physiology, not a sign that something has gone wrong. Similarly, the gradual HRV drop that accompanies perimenopause and menopause is part of the expected trajectory, though a sharper-than-expected decline, especially in the high-frequency component, is worth mentioning to a clinician given its association with cardiovascular risk.